IE
ELV icon

Israel Englander’s Elevance Health ELV Stock Holding History

Israel Englander’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.67M Buy
25,000
+100
+0.4% +$37.1K ﹤0.01% 2313
2026
Q1 		$7.29M Sell
24,900
-7,100
-22% -$2.33M ﹤0.01% 2522
2025
Q4 		$11.2M Buy
32,000
+14,600
+84% +$4.93M ﹤0.01% 2140
2025
Q3 		$5.62M Sell
17,400
-20,000
-53% -$6.22M ﹤0.01% 3019
2025
Q2 		$14.5M Sell
37,400
-81,500
-69% -$32.8M 0.01% 1890
2025
Q1 		$51.7M Buy
118,900
+101,200
+572% +$40.6M 0.03% 749
2024
Q4 		$6.53M Sell
17,700
-26,000
-59% -$10.9M ﹤0.01% 2583
2024
Q3 		$22.7M Sell
43,700
-23,400
-35% -$12.5M 0.01% 1436
2024
Q2 		$36.4M Sell
67,100
-100
-0.1% -$52.9K 0.02% 1013
2024
Q1 		$34.8M Sell
67,200
-53,700
-44% -$26.7M 0.01% 1075
2023
Q4 		$57M Buy
120,900
+40,400
+50% +$18.7M 0.02% 715
2023
Q3 		$35.1M Sell
80,500
-25,900
-24% -$11.7M 0.02% 959
2023
Q2 		$47.3M Sell
106,400
-30,900
-23% -$14.3M 0.02% 773
2023
Q1 		$63.1M Sell
137,300
-66,000
-32% -$31.4M 0.04% 565
2022
Q4 		$104M Buy
203,300
+118,700
+140% +$60.3M 0.06% 360
2022
Q3 		$38.4M Buy
84,600
+46,500
+122% +$22.2M 0.02% 843
2022
Q2 		$18.4M Sell
38,100
-4,900
-11% -$2.42M 0.01% 1399
2022
Q1 		$21.1M Sell
43,000
-39,300
-48% -$18M 0.01% 1337
2021
Q4 		$38.1M Buy
82,300
+7,600
+10% +$3.2M 0.02% 905
2021
Q3 		$27.8M Buy
74,700
+45,300
+154% +$17.2M 0.02% 1033
2021
Q2 		$11.2M Buy
29,400
+26,600
+950% +$10.2M 0.01% 1754
2021
Q1 		$1M Sell
2,800
-9,200
-77% -$2.96M ﹤0.01% 4215
2020
Q4 		$3.85M Sell
12,000
-3,000
-20% -$921K ﹤0.01% 2701
2020
Q3 		$4.03K Buy
15,000
+13,100
+689% +$3.52M 0.01% 2037
2020
Q2 		$500K Buy
+1,900
New +$507K ﹤0.01% 3402
2020
Q1 		– Sell
-1,600
Closed -$483K – 4011
2019
Q4 		$483K Buy
+1,600
New +$440K ﹤0.01% 3401
2019
Q2 		– Sell
-3,000
Closed -$861K – 4140
2019
Q1 		$861K Buy
+3,000
New +$868K ﹤0.01% 2954

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Israel Englander's ELV Position: Q2 2026 in Review

Israel Englander reduced its Elevance Health (ELV) stake by 21% in Q2 2026, selling an estimated $71.1M and leaving 727,561 shares worth $281M. The position accounts for 0.1% of the portfolio, ranked #154.

Israel Englander first reported a position in ELV in Q2 2013 and has held it in 50 quarters since. The position peaked at $431M in Q3 2023. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Israel Englander held 727,561 shares of Elevance Health worth $281M as of Q2 2026.
  • Israel Englander sold 191,610 Elevance Health shares in Q2 2026, an estimated $71.1M.
  • Elevance Health made up 0.1% of Israel Englander's portfolio in Q2 2026, its #154 holding.
  • Israel Englander first reported a position in Elevance Health in Q2 2013 and has held it in 50 quarters since.
  • Israel Englander's Elevance Health position peaked at $431M in Q3 2023.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.